Search Results - "MICHALOVA, K"

Separation of replication and transcription domains in nucleoli by Smirnov, E., Borkovec, J., Kováčik, L., Svidenská, S., Schröfel, A., Skalníková, M., Švindrych, Z., Křížek, P., Ovesný, M., Hagen, G.M., Juda, P., Michalová, K., Cardoso, M.C., Cmarko, D., Raška, I.

“…In mammalian cells, active ribosomal genes produce the 18S, 5.8S and 28S RNAs of ribosomal particles. Transcription levels of these genes are very high…”
Get full text

Hereditary haemochromatosis caused by homozygous HJV mutation evolved through paternal disomy by Neřoldová, M., Fraňková, S., Stránecký, V., Honsová, E., Lukšan, O., Beneš, M., Michalová, K., Kmoch, S., Jirsa, M.

Get full text

MiR-155/miR-150 network regulates progression through the disease phases of chronic lymphocytic leukemia by Vargova, K, Pesta, M, Obrtlikova, P, Dusilkova, N, Minarik, L, Vargova, J, Berkova, A, Zemanova, Z, Michalova, K, Spacek, M, Trneny, M, Stopka, T

Get full text

High Level of Full-Length Cereblon Messenger RNA and Protein is Important for Lenalidomide Efficacy in Lower Risk MDS Patients by Fuchs, O, Polak, J, Bokorova, R, Kostecka, A, Vostry, M, Neuwirtova, R, Siskova, M, Stopka, T, Lauermannova, M, Maaloufova, J. Soukupova, Salek, C, Mikulenkova, D, Cermak, J, Brezinova, J, Zemanova, Z, Michalova, K, Jonasova, A

Get full text

Lenalidomide Treatment in Lower Risk MDS – The Experience of One Czech Center (Positive Effect of Erythropoietin ± Prednisone Addition) by Jonasova, A, Neuwirtova, R, Polackova, H, Siskova, M, Tomas, S, Cmunt, E, Belickova, M, Fuchs, O, Moudra, A, Michalova, K, Zemanova, Z

Get full text

Cytogenetic Clonal Evolution in Myelodysplastic Syndromes (MDS) with Isolated Del(5Q) by Zemanova, Z, Michalova, K, Brezinova, J, Svobodova, K, Lhotska, H, Sarova, I, Lizcova, L, Izakova, S, Ransdorfova, S, Pavlistova, L, Berkova, A, Skipalova, K, Belickova, M, Siskova, M, Neuwirtova, R, Cermak, J, Stopka, T, Jonasova, A

Get full text

MDS Patients with Del(5Q) and Trisomy 8 in Two Independent Clones Have High fli-1 and Cereblon Messenger RNA Levels by Fuchs, O, Polak, J, Bokorova, R, Kostecka, A, Vostry, M, Jonasova, A, Myslivcova, D, Siskova, M, Stopka, T, Lauermannova, M, Salek, C, Maaloufova, J. Soukupova, Mikulenkova, D, Cermak, J, Brezinova, J, Zemanova, Z, Michalova, K, Neuwirtova, R

Get full text

106 PATIENTS WITH TWO UNRELATED CLONES DEL(5Q) AND TRISOMY 8 – A SUBTYPE OF 5Q- SYNDOME? UNCERTAIN PROGNOSIS OF PATIENTS WITH DECREASED DEL(5Q) CLONE DUE TO LENALIDOMIDE by Neuwirtova, R, Zemanova, Z, Brezinova, J, Michalova, K, Dvorak, P, Oltova, A, Belickova, M, Fuchs, O, Cermak, J, Jonasova, A

Get full text

49 THE PROGNOSTIC SIGNIFICANCE OF TP53 MUTATIONS IN MDS PATIENTS WITH DEL(5Q) by Belickova, M, Vesela, J, Jonasova, A, Planetova, B, Valka, J, Mikulenkova, D, Zemanova, Z, Brezinova, J, Michalova, K, Cermak, J

Get full text

170 MECHANISM OF FORMATION OF COMPLEX CHROMOSOMAL ABERRATIONS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS): CLONAL EVOLUTION OR CHROMOTHRIPSIS? by Zemanova, Z, Michalova, K, Brezinova, J, Lhotska, H, Svobodova, K, Sarova, I, Lizcova, L, Izakova, S, Ransdorfova, S, Krejcik, Z, Belickova, M, Siskova, M, Jonasova, A, Neuwirtova, R, Cermak, J

Get full text

42 THE EFFICACY OF LENALIDOMIDE IN LOWER RISK MYELODYSPLASTIC SYNDROME WITH ISOLATED 5Q DELETION IS DEPENDENT ON HIGH LEVEL OF FULL-LENGTH CEREBLON MESSENGER RNA by Fuchs, O, Polak, J, Bokorova, R, Vostry, M, Kostecka, A, Hajkova, H, Neuwirtova, R, Siskova, M, Cermak, J, Sponerova, D, Lauermannova, M, Soukupova, J, Cervinek, L, Brezinova, J, Michalova, K, Jonasova, A

Get full text

The effect of allogeneic stem cell transplantation on high risk chronic lymphocytic leukaemia: a single centre retrospective analysis by Válková, V, Schwarz, J, Vítek, A, Marková, M, Pohlreich, D, Benešová, K, Michalová, K, Cetkovský, P, Trněný, M

“…In recent years, many studies have confirmed that allogeneic stem cell transplantation (allo‐SCT) can provide long‐term disease control and possible cure in…”
Get full text

R‐CHOP/R‐HDAC AND RITUXIMAB MAINTENANCE RESULTS IN HIGH COMPLETE REMISSION RATE, MINIMAL RESIDUAL DISEASE NEGATIVITY, AND EXCELLENT SURVIVAL IN ELDERLY MCL PATIENTS by Klener, P., Fronkova, E., Belada, D., Forsterova, K., Pytlik, R., Kalinova, M., Simkovic, M., Salek, D., Mocikova, H., Prochazka, V., Blahovcová, P., Janikova, A., Markova, J., Obr, A., Berkova, A., Vaskova, M., Mejstrikova, E., Campr, V., Kubinyi, J., Jaksa, R., Kodet, R., Michalova, K., Trka, J., Trneny, M.

Get full text

Frequent chromatin rearrangements in myelodysplastic syndromes--what stands behind? by Pagáčová, E, Falk, M, Falková, I, Lukášová, E, Michalová, K, Oltová, A, Raška, I, Kozubek, S

“…Myelodysplastic syndromes (MDS) represent a clinically and genetically heterogeneous group of clonal haematopoietic diseases characterized by a short survival…”
Get full text

P-231 The role of Fli1 and p53 for the effective megakaryopoiesis in 5q-syndrome by Neuwirtova, R, Stritesky, J, Fuchs, O, Vostry, M, Kostecka, A, Siskova, M, Michalova, K, Jonasova, A

Get full text

P-220 A comparison of effect of stem cell transplantation (SCT) with different treatment approaches on long term survival of MDS patients by Cermak, J, Vitek, A, Mikulenkova, D, Lukasova, M, Michalova, K, Brezinova, J, Markova-Stastna, M, Cetkovsky, P

Get full text

Fluorescence in situ hybridization applied to domestic animal cytogenetics by Rubes, J, Pinton, A, Bonnet-Garnier, A, Fillon, V, Musilova, P, Michalova, K, Kubickova, S, Ducos, A, Yerle, M

“…The aim of this article is not to present an exhaustive review of molecular cytogenetics applications in domestic animal species, but more to illustrate the…”
Get more information

Interstitial del(14)(q) involving IGH: a novel recurrent aberration in B-NHL by Pospisilova, H, Baens, M, Michaux, L, Stul, M, Van Hummelen, P, Van Loo, P, Vermeesch, J, Jarosova, M, Zemanova, Z, Michalova, K, Van den Berghe, I, Alexander, H D, Hagemeijer, A, Vandenberghe, P, Cools, J, De Wolf-Peeters, C, Marynen, P, Wlodarska, I

Get full text

P026 A limited benefit of isolated 5q deletion on prognosis – results of a long term retrospective analysis by Cermak, J, Mikulenkova, D, Brezinova, J, Michalova, K

Get full text

Ranibizumab treatment for neovascular age-related macular degeneration: from randomized trials to clinical practice by Michalova, K, Wickremasinghe, S S, Tan, T H, Chang, A, Harper, C A, Downie, J A, Hunyor, A P, Guymer, R H

“…Background Although randomized clinical trials (ANCHOR and MARINA) have shown excellent results of ranibizumab treatment in patients with neovascular…”
Get full text